<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04691128</url>
  </required_header>
  <id_info>
    <org_study_id>H199510180629</org_study_id>
    <nct_id>NCT04691128</nct_id>
  </id_info>
  <brief_title>Desflurane and Brain Relaxation in Craniotomy</brief_title>
  <official_title>Comparison of Desflurane and Propofol for Brain Relaxation in Patients Undergoing Supratentorial Craniotomy：a Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Optional brain relaxation improves the surgeon's operating conditions and is likely to&#xD;
      minimize the degree of retraction injury ,with the potential for providing patients with a&#xD;
      better outcome. The choice of anesthetic drugs can affect intraoperative brain relaxation.&#xD;
      Propofol suppresses brain metabolism, reduces cerebral blood flow, and provides satisfactory&#xD;
      brain relaxation. Desflurane is often criticized in neurosurgery due to its cerebral&#xD;
      vasodilation and potential to increase intracranial pressure, however, it has been found to&#xD;
      have a little clinical significance. This study intends to compare the effects of desflurane&#xD;
      with propofol on brain relaxation in patients with supratentorial tumors under mild&#xD;
      hyperventilation, and to provide new clinical evidence for the use of desflurane in&#xD;
      neurosurgical anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare the effect of desflurane versus propofol combined with remifentanil anesthesia on&#xD;
      brain relaxation in patients undergoing supratentorial tumor surgery with mild&#xD;
      hyperventilation, and compare the emergence time and common complications during recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 26, 2021</start_date>
  <completion_date type="Actual">August 31, 2021</completion_date>
  <primary_completion_date type="Actual">August 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of satisfactory brain relaxation</measure>
    <time_frame>during surgery</time_frame>
    <description>Assessed by the neurosurgeon using a 4-point scale (1= perfectly relaxed, 2= satisfactorily relaxed, 3= firm brain, 4=bulging brain) at the opening of the dura mater, score 1 and 2 represent satisfactory brain relaxation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Emergence time</measure>
    <time_frame>from drug discontinuation to eye opening, assessed up to 1 hours</time_frame>
    <description>from drug discontinuation to eye opening</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extubation time</measure>
    <time_frame>from drug discontinuation to tracheal extubation, assessed up to 1 hours</time_frame>
    <description>from drug discontinuation to tracheal extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>from drug discontinuation to discharge from PACU (Postanesthesia care unit), assessed up to 3 hours</time_frame>
    <description>incidence of hypoxemia, hypotension, hypertension, tachycardia, bradycardia, agitation, shivering.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative pain and postoperative nausea and vomiting (PONV)</measure>
    <time_frame>during the PACU stay and postoperative day 1.</time_frame>
    <description>evaluated by Visual Analogue Score(VAS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration in PACU (Postanesthesia care unit)</measure>
    <time_frame>from entering PACU to exiting PACU, an expected average of 1 hour</time_frame>
    <description>time from entering PACU to exiting PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early postanesthesia cognitive recovery</measure>
    <time_frame>at 15, 30min after tracheal extubation</time_frame>
    <description>evaluated by Short Orientation Memory Concentration Test (SOMCT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dural tension</measure>
    <time_frame>during surgery</time_frame>
    <description>evaluated using a 4-point scale after bone flap removal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of anesthesia recovery</measure>
    <time_frame>at postoperative day 1</time_frame>
    <description>assessed by quality of recovery-15 scale (QoR-15)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anesthesia expenses</measure>
    <time_frame>at postoperative day 1</time_frame>
    <description>Total cost of anesthesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">111</enrollment>
  <condition>Supratentorial Tumor</condition>
  <arm_group>
    <arm_group_label>Desflurane inhalational anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol total intravenous anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>After induction, anesthesia will be maintained with 0.8-1.3 MAC desflurane and 0.05-0.2 μg/kg/min remifentanil.</description>
    <arm_group_label>Desflurane inhalational anesthesia</arm_group_label>
    <other_name>inhalational anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>After induction, anesthesia will be maintained with 6-8 mg/kg/h propofol and 0.05- 0.2 μg/kg/min remifentanil</description>
    <arm_group_label>Propofol total intravenous anesthesia</arm_group_label>
    <other_name>TIVA</other_name>
    <other_name>total intravenous anesthesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-60 years&#xD;
&#xD;
          -  Scheduled for elective craniotomy for supratentorial cerebral tumors&#xD;
&#xD;
          -  ASA status I-III&#xD;
&#xD;
          -  Glasgow score of 15&#xD;
&#xD;
          -  No clinical signs of intracranial hypertension&#xD;
&#xD;
          -  Preoperative brain imaging (CT or MRI) with midline shift less than 5mm&#xD;
&#xD;
          -  Informed consent signed by patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Scheduled intraoperative motor evoked potential monitoring&#xD;
&#xD;
          -  Patients with cerebral vascular diseases&#xD;
&#xD;
          -  Uncontrolled cardiopulmonary disease&#xD;
&#xD;
          -  Schedule to retain tracheal intubation after surgery&#xD;
&#xD;
          -  Unable to comprehend and cooperate with the examination&#xD;
&#xD;
          -  BMI &gt; 30 Kg/m-2&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  History of related anesthetic allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100070</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 12, 2020</study_first_submitted>
  <study_first_submitted_qc>December 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 31, 2020</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Ruquan Han</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Supratentorial Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

